Construction of a regression model and post-procedure care strategy for predicting atrial fibrillation recurrence risk after radiofrequency ablation using combined P-wave electrocardiographic markers and serum - Takeaways - MDSpire

Construction of a regression model and post-procedure care strategy for predicting atrial fibrillation recurrence risk after radiofrequency ablation using combined P-wave electrocardiographic markers and serum

  • By

  • Dong Zhao

  • Yahong Chen

  • Hongwei Zhang

  • Lixia Yang

  • May 13, 2026

Share

  • 1

    A predictive nomogram was developed combining P-wave ECG markers and serum BNP levels to assess atrial fibrillation recurrence risk post-ablation.

  • 2

    The study involved 200 atrial fibrillation patients, with 62 experiencing recurrence and 138 remaining free of recurrence at the 3-month follow-up.

  • 3

    Significant differences in AF type, left atrial diameter, P-wave duration, and BNP levels were found between recurrence and non-recurrence groups.

  • 4

    Logistic regression identified AF type, left atrial diameter, P-wave parameters, and BNP as independent risk factors for recurrence after RFA.

  • 5

    The nomogram demonstrated high predictive accuracy with an AUC of 0.959, aiding in risk stratification and personalized follow-up care strategies.

Original Source(s)

Construction of a regression model and post-procedure care strategy for predicting atrial fibrillation recurrence risk after radiofrequency ablation using combined P-wave electrocardiographic markers and serum

  • by Dong Zhao, Yahong Chen, Hongwei Zhang, Lixia Yang

  • May 13, 2026

Related Content

New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min
Innovative, Minimally Invasive Treatment for Drug-Resistant Epilepsy

Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.

  • by

  • May 8, 2026

  • 5 min